Genotypes and haplotypes of β2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents

Metabolism: Clinical and Experimental

Volumn 57, Issue 8, 2008, Pages 1064-1070

  Park, Hye Soon ^a   Shin, Eun Soon ^b   Lee, Jong Eun ^c  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c DNA Link Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; CHOLESTEROL; DNA;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INSULIN BLOOD LEVEL; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANTHROPOMETRY; BLOOD; CHEMISTRY; GENETIC VARIABILITY; GENETICS; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ADOLESCENT; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DNA; FEMALE; HAPLOTYPES; HUMANS; INSULIN; KOREA; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 47149087763     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.03.009     Document Type: Article

References (30)

1. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
2. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
3. Cook S., Weitzman M., Auinger P., Nguyen M., and Dietz W.H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157 (2003) 821-827
4. de Ferranti S.D., Gauvreau K., Ludwig D.S., Neufeld E.J., Newburger J.W., and Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110 (2004) 2494-2497
5. Duncan G.E., Li S.M., and Zhou X.H. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care 27 (2004) 2438-2443
6. Goodman E., Daniels S.R., Morrison J.A., Huang B., and Dolan L.M. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 145 (2004) 445-451
7. Atabek M.E., Pirgon O., and Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 72 (2006) 315-321
8. Park H.S., Han J.H., Choi K.M., and Kim S.M. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 82 (2005) 1046-1051
9. Ozanne S.E., and Hales C.N. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab 13 (2002) 368-373
10. Pereira A.C., Floriano M.S., Mota G.F., et al. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 42 (2003) 685-692
11. Ukkola O., Rankinen T., Weisnagel S.J., et al. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 49 (2000) 1063-1070
12. Kim S.H., Kim D.J., Seo I.A., et al. Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism 51 (2002) 833-837
13. Rosmond R., Ukkola O., Chagnon M., Bouchard C., and Bjorntorp P. Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 248 (2000) 239-244
14. Park H.S., Kim Y., and Lee C. Single nucleotide variants in the beta2-adrenergic and beta3-adrenergic receptor genes explained 18.3% of adolescent obesity variation. J Hum Genet 50 (2005) 365-369
15. Dallongeville J., Helbecque N., Cottel D., Amouyel P., and Meirhaeghe A. The Gly16->Arg16 and Gln27->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 88 (2003) 4862-4866
16. Cha K., Chertow G.M., Gonzalez J., Lazarus J.M., and Wilmore D.W. Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol 79 (1995) 1316-1319
17. WHO. Obesity: preventing and managing the global epidemic (1998), WHO, Geneva
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Carmelli D., Cardon L.R., and Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments?. Am J Hum Genet 55 (1994) 566-573
20. Insel P.A. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors-evolving concepts and clinical implications. N Engl J Med 334 (1996) 580-585
21. Ishiyama-Shigemoto S., Yamada K., Yuan X., Ichikawa F., and Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42 (1999) 98-101
22. McGraw D.W., Forbes S.L., Kramer L.A., and Liggett S.B. Polymorphisms of the 5¢ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 102 (1998) 1927-1932
23. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
24. Ellsworth D.L., Coady S.A., Chen W., et al. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 26 (2002) 928-937
25. Matsuoka H., Iwama S., Miura N., Ikezaki A., and Sugihara S. Impact of polymorphisms of beta2- and beta3-adrenergic receptor genes on longitudinal changes in obesity in early childhood. Acta Paediatr 93 (2004) 430
26. Tafel J., Branscheid I., Skwarna B., et al. Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents. Diabetes Obes Metab 6 (2004) 452-455
27. Weiss R., Dziura J., Burgert T.S., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
28. Bowcock A.M. Genomics: guilt by association. Nature 447 (2007) 655-660
29. Haffner S.M., Miettinen H., and Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 20 (1997) 1087-1092
30. Hermans M.P., Levy J.C., Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42 (1999) 678-687